Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Find out How Index Funds are Traded, Priced & Potential Issues You May Face

Mutualfunds logo

FSPHX Fidelity® Select Health Care

  • Fund
  • FSPHX
  • Price as of: Jul 19, 2017
  • $228.59
  • + $2.39
  • + 1.06%
  • Category
  • Health & Biotech Equities

FSPHX - Profile

Vitals

  • YTD Return 23.7%
  • 3 Yr Annualized Return 9.8%
  • 5 Yr Annualized Return 20.8%
  • Net Assets $6.8 B
  • Holdings in Top 10 50.2%

52 WEEK LOW AND HIGH

$228.59
$176.65
$228.59

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.74%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 49.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

STANDARD (TAXABLE)

$2,500

IRA

$2,500

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 23.7%
  • 3 Yr Annualized Total Return 9.8%
  • 5 Yr Annualized Total Return 20.8%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 0.12%
DIVIDENDS
  • Dividend Yield 0.1%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name Fidelity® Select Health Care Portfolio
  • Fund Family Name Fidelity Investments
  • Inception Date Jul 14, 1981
  • Shares Outstanding N/A
  • Share Class No Load
  • Currency USD
  • Domiciled Country United States
  • Manager Edward L. Yoon

Fund Description

The Fidelity Select Health Care Portfolio (FSPHX) offers investors exposure to the healthcare industry, investing primarily in companies engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. FSPHX aims to outperform the MSCI U.S. IMI Health Care 25-50 Index through active management.

The fund utilizes fundamental, bottom-up research, screening securities on normalized free cash flow per share, market opportunity, sales growth, margin outlook and capital deployment to value ideas. The resulting portfolio features exposure to both domestic and non-U.S. developed market equities; the portfolio primarily consists of large capitalization growth stocks.

FSPHX - Performance

Return Ranking - Trailing

Period FSPHX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 23.7% -14.9% 31.1% 18.75% 1
1 Yr 16.7% -14.8% 43.3% 44.14% 3
3 Yr 9.8% * -7.5% 18.2% 36.11% 2
5 Yr 20.8% * 9.3% 21.8% 5.83% 1
10 Yr 13.1% * 6.1% 15.7% 29.29% 2

* Annualized


Return Ranking - Calendar

Period FSPHX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -11.2% -29.8% 2.6% 27.27% 2
2015 -4.4% -20.4% 14.5% 64.55% 4
2014 15.5% -5.8% 33.7% 55.45% 3
2013 40.6% -2.6% 65.2% 48.62% 3
2012 9.6% -5.3% 36.5% 72.82% 4

Total Return Ranking - Trailing

Period FSPHX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 23.7% -14.9% 31.1% 18.92% 1
1 Yr 16.7% -18.3% 41.2% 40.91% 3
3 Yr 9.8% * -14.2% 18.2% 33.33% 2
5 Yr 20.8% * 9.1% 21.8% 4.85% 1
10 Yr 13.1% * 6.1% 15.7% 26.26% 2

* Annualized


Total Return Ranking - Calendar

Period FSPHX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -11.2% -25.1% 6.3% 31.19% 2
2015 7.6% -16.6% 39.1% 53.21% 3
2014 44.2% -5.8% 100.0% 17.43% 1
2013 123.1% -5.1% 398.7% 9.26% 1
2012 75.2% -2.6% 475.8% 12.00% 1

NAV & Total Return History

FSPHX - Holdings

Filings data as of: May 31, 2017

Concentration Analysis

FSPHX Category Low Category High FSPHX % Rank Quintile
Net Assets 6.8 B 20.8 M 48.3 B 4.46% 1
Number of Holdings 97 32 365 11.61% 2
Net Assets in Top 10 3.2 B 9.25 M 20.1 B 4.46% 1
Weighting of Top 10 50.2% 19.5% 71.8% 7.14% 1

Top 10 Holdings

  1. Allergan PLC 7.01%
  2. Boston Scientific Corp 5.08%
  3. Medtronic PLC 6.52%
  4. UnitedHealth Group Inc 6.59%
  5. Amgen Inc 9.00%
  6. Vertex Pharmaceuticals Inc 3.06%
  7. Bristol-Myers Squibb Company 3.62%
  8. Intuitive Surgical Inc 3.90%
  9. Aetna Inc 2.91%
  10. Cigna Corp 2.53%

Asset Allocation

Weighting Category Low Category High FSPHX % Rank Quintile
Stocks
99.95% 85.65% 102.85% 3.57% 1
Cash
0.05% -0.06% 14.35% 27.68% 4
Preferred Stocks
0.00% 0.00% 0.71% 5.36% 5
Other
0.00% -11.71% 7.50% 16.07% 5
Convertible Bonds
0.00% 0.00% 0.49% 3.57% 5
Bonds
0.00% 0.00% 5.97% 4.46% 5

Stock Sector Breakdown

Weighting Category Low Category High FSPHX % Rank Quintile
Healthcare
91.93% 11.52% 99.64% 28.57% 4
Technology
5.91% 0.00% 64.38% 2.68% 1
Industrials
0.49% 0.00% 8.05% 5.36% 1
Consumer Cyclical
0.30% 0.00% 5.10% 4.46% 1
Consumer Defense
0.06% 0.00% 2.14% 12.50% 2
Utilities
0.00% 0.00% 1.11% 1.79% 5
Real Estate
0.00% 0.00% 1.50% 2.68% 5
Financial Services
0.00% 0.00% 5.16% 6.25% 5
Energy
0.00% 0.00% 0.00% 0.89% 5
Communication Services
0.00% 0.00% 0.00% 0.89% 5
Basic Materials
0.00% 0.00% 1.96% 4.46% 5

Stock Geographic Breakdown

Weighting Category Low Category High FSPHX % Rank Quintile
US
92.71% 59.77% 99.64% 10.71% 1
Non US
7.24% 0.00% 40.28% 20.54% 4

FSPHX - Expenses

Operational Fees

FSPHX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 0.74% 0.10% 4.31% 69.64% 1
Management Fee 0.55% 0.09% 1.25% 14.29% 1
12b-1 Fee N/A 0.00% 1.00% N/A N/A
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

FSPHX Fees (% of AUM) Category Low Category High FSPHX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

FSPHX Fees (% of AUM) Category Low Category High FSPHX Rank Quintile
Max Redemption Fee 0.75% 0.75% 2.00% 6.82% 2

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FSPHX Fees (% of AUM) Category Low Category High FSPHX Rank Quintile
Turnover 49.00% 0.00% 699.00% 15.18% 4

FSPHX - Distributions

Dividend Yield Analysis

FSPHX Category Low Category High FSPHX % Rank Quintile
Dividend Yield 0.1% 0.01% 0.94% 53.19% 3

Dividend Distribution Analysis

FSPHX Category Low Category High Category Mode
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

FSPHX Category Low Category High FSPHX % Rank Quintile
Net Income Ratio 0.12% -2.22% 1.40% 19.64% 2

Capital Gain Distribution Analysis

FSPHX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

FSPHX - Managers

Edward L. Yoon

Manager

Start Date

Oct 01, 2008

Tenure

8.75

Tenure Rank

12.6%

Edward Yoon is a manager. Since joining Fidelity Investments in 2006, Mr. Yoon has served as a research analyst and portfolio manager. Prior to joining Fidelity, he worked for JPMorgan Asset Management as a research analyst and co-fund manager from 2002 until 2006. Mr. Yoon received a BA in business economics from Brown University in 2002.


Tenure Analysis

Category Low

0.0

Category High

19.8

Category Average

8.78

Category Mode

2.5